Neova Technologies Inc. draws on almost thirty years of expertise in bioseparation and protein fractionation, building its international reputation on quality and service. Neova Technologies takes an integrated approach to product development and quality enhancement. With a strong history in research and development to support the products we sell, our approach is to seek practical solutions that regularly challenge current limits and assumptions. Neova Technologies produces purified enzymes extracted from government-certified beef and pork pancreas glands. These enzymes are naturally occurring pancreatic proteins that play an important role in the digestion of food. The two main enzymes, trypsin and chymotrypsin, are refined and blended to meet different functional requirements as determined in consultation with customers. Our natural enzymes are largely used in Baby Foods and Infant formulas where safety and quality’s benchmark are strictly required for newborn’s food and childrens’ health thus availing the value of efforts and commitments shared by Neova Technologies. Trypsin and chymotrypsin are classified as serine proteases, with specific cleaving characteristics. Trypsin preferentially hydrolyzes bonds whose carboxyl groups are contributed by lysine (Lys) or arginine (Arg). Chymotrypsin hydrolyzes peptide bonds involving phenylalanine (Phe), tyrosine (Tyr) and tryptophan (Try).
Phospholipase (PA2) is a standardized product, which cleaves the fatty acid at the second position in phospholipids.